Schedule 13G ownership disclosure

Collegium Pharmaceutical Inc

Common Stock · CUSIP: 19459J104

Event date: 2026-09-30

Filing-level shares
1,261,037.00
Percent of class
3.9%
  • Invesco Ltd.

    Shares: 1,261,037.00 · Class: 3.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-26-000400
Form type
SCHEDULE 13G/A
Filer
COLLEGIUM PHARMACEUTICAL, INC
CIK
CIK 1267565
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub